Weiss, Rivka
Weiss, Rivka was paid $100K by Medicaid between Feb 2020 and Sep 2024, across 19 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 68% of everything it billed.
33Billing provider infoWEISS, RIVKA
VALLEY COTTAGE, NY 10989
VALLEY COTTAGE, NY 10989
33aNPI1952859969assigned 09/19/2016
33bProvider typeRegistered Nurse
28Total paid$100K
24GClaims3,927
24DCodes billed19
24AFirst – last monthFeb 2020 – Sep 2024
Compared with peers
Next to other Registered Nurse providers in New York
Rank by total paid#13 of 355
Median peer was paid$2K
This provider vs. median50×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 706 | $8K | |
| 2021 | 643 | $7K | |
| 2022 | 1,601 | $74K | |
| 2023 | 821 | $8K | |
| 2024incomplete | 156 | $2K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 68% | 1,465 | 642 | $68K |
| 99305 | 12% | 887 | 885 | $12K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 4.4% | 474 | 443 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.2% | 66 | 50 | $4K |
| 99308 | Subsequent nursing facility care, per day, straightforward | 3.3% | 535 | 407 | $3K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.6% | 46 | 46 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.4% | 47 | 37 | $1K |
| 87428 | 1.2% | 17 | 15 | $1K | |
| 90674 | <1% | 55 | 29 | $876.90 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 57 | 57 | $740.25 |
| 99326 | <1% | 39 | 39 | $592.29 | |
| 90688 | <1% | 53 | 29 | $518.33 |
7 more codes
| 99441 | <1% | 15 | $505.47 | |
| 99306 | Prolong nursin fac eval 15m | <1% | 14 | $392.35 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 48 | $191.67 |
| 99442 | <1% | 12 | $63.29 | |
| 99335 | <1% | 13 | $51.00 | |
| G0008 | Administration of influenza virus vaccine | <1% | 58 | $13.23 |
| 99325 | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.